Literature DB >> 9354431

Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases.

S Tommasi1, M F Denissenko, G P Pfeifer.   

Abstract

The most prevalent DNA lesion induced by UV irradiation is the cyclobutane pyrimidine dimer (CPD), which forms at positions of neighboring pyrimidines. Here we show that the rare DNA base 5-methylcytosine is the preferred target for CPD formation when cells are irradiated with natural sunlight. We have mapped the distribution of CPDs formed in normal human keratinocytes along exons of the p53 gene. Codons 196, 245, 248, and 282, which are mutational hot spots in skin cancers, are only weakly to moderately susceptible to formation of CPDs after irradiation with UVC (254 nm) or UVB (320 nm) light sources. However, when cells were exposed to natural sunlight, CPD formation was enhanced up to 15-fold at these codons due to the presence of 5-methylcytosine bases. These results suggest that CPDs containing 5-methylcytosine may play an important role in formation of sunlight-induced skin tumors and that methylation of CpG sequences, besides being involved in spontaneous mutagenesis processes, can also create preferential targets for environmental mutagens and carcinogens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9354431

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

1.  Cell cycle-independent removal of UV-induced pyrimidine dimers from the promoter and the transcription initiation domain of the human CDC2 gene.

Authors:  S Tommasi; A B Oxyzoglou; G P Pfeifer
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

2.  Rotational position of a 5-methylcytosine-containing cyclobutane pyrimidine dimer in a nucleosome greatly affects its deamination rate.

Authors:  Qian Song; Vincent J Cannistraro; John-Stephen Taylor
Journal:  J Biol Chem       Date:  2010-12-15       Impact factor: 5.157

3.  Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice.

Authors:  Vijayalakshmi Nandakumar; Mudit Vaid; Trygve O Tollefsbol; Santosh K Katiyar
Journal:  Carcinogenesis       Date:  2010-12-24       Impact factor: 4.944

Review 4.  DNA hypomethylation in the origin and pathogenesis of human diseases.

Authors:  Igor P Pogribny; Frederick A Beland
Journal:  Cell Mol Life Sci       Date:  2009-03-27       Impact factor: 9.261

Review 5.  p53 and the pathogenesis of skin cancer.

Authors:  Cara L Benjamin; Honnavara N Ananthaswamy
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-15       Impact factor: 4.219

Review 6.  Epigenetic alterations in ultraviolet radiation-induced skin carcinogenesis: interaction of bioactive dietary components on epigenetic targets.

Authors:  Santosh K Katiyar; Tripti Singh; Ram Prasad; Qian Sun; Mudit Vaid
Journal:  Photochem Photobiol       Date:  2011-11-17       Impact factor: 3.421

7.  Acceleration of 5-methylcytosine deamination in cyclobutane dimers by G and its implications for UV-induced C-to-T mutation hotspots.

Authors:  Vincent J Cannistraro; John-Stephen Taylor
Journal:  J Mol Biol       Date:  2009-07-22       Impact factor: 5.469

8.  Cytosine Methylation Affects the Mutability of Neighboring Nucleotides in Germline and Soma.

Authors:  Vassili Kusmartsev; Magdalena Drożdż; Benjamin Schuster-Böckler; Tobias Warnecke
Journal:  Genetics       Date:  2020-02-20       Impact factor: 4.562

Review 9.  Light, including ultraviolet.

Authors:  Emanual Maverakis; Yoshinori Miyamura; Michael P Bowen; Genevieve Correa; Yoko Ono; Heidi Goodarzi
Journal:  J Autoimmun       Date:  2009-12-16       Impact factor: 7.094

10.  Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene.

Authors:  Zhipei Liu; Manfred Hergenhahn; Heinz H Schmeiser; Gerald N Wogan; Amanda Hong; Monica Hollstein
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.